Risk of adverse events, including those that may be due to zinc supplements Duration of · adults and children with colds and/or upper respiratory infections
1 finding from 1 review
Risk of adverse events, including those that may be due to zinc supplements Duration of · adults and children without colds
1 finding from 1 review
Risk of serious adverse events, including those that may be complications of the common cold · adults and children with colds and/or upper respiratory infections
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of serious adverse events, including those that may be complications of the common cold Duration of · adults and children without colds
1 finding from 1 review
Adverse events associated with treatment · ulceration and other skin changes caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Priimary outcome: adverse events · ulceration caused by nerve damage in leprosy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · healthy women, aged 35 to 60, and men, aged 45 to 60, living in France
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with diabetes and foot ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Primary outcome: adverse events (skin sensitisation at 2 months) · ulceration caused by nerve damage in leprosy
1 finding from 1 review
Adverse events number of participants hospitalised during the trial · children with cystic fibrosis
Summary of findings: Zinc supplementation showed no clear difference in adverse events number of participants hospitalised during the trial compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · non‐diabetic adults with insulin resistance
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events (vomiting) · children aged less than 6 months with acute diarrhoea
The intervention probably leads to higher adverse events (vomiting) (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events (vomiting) · children with persistent diarrhoea
It is very uncertain whether the intervention changes adverse events (vomiting) (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events (vomiting) · children with acute diarrhoea
The intervention probably leads to higher adverse events (vomiting) (moderate certainty).
1 finding from 1 review
Primary outcome: adverse events (assessed at 3 months as minimum, moderate or severe) · ulceration caused by nerve damage in leprosy
1 finding from 1 review